Tyrosine kinase inhibitors as cancer therapy

被引：6
|
作者：
Nichols, GL
机构：
[1] Columbia Univ Coll Phys & Surg, Dept Med, Div Hematol, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Med, Div Oncol, New York, NY 10032 USA
来源：
CANCER INVESTIGATION | 2003年 / 21卷 / 05期
关键词：
tyrosine kinases; signal transduction; tyrosine kinase inhibitors; cancer therapy;
D O I：
10.1081/CNV-120023774
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：758 / 771
页数：14
相关论文
共 50 条
  • [1] Tyrosine kinase inhibitors in cancer therapy
    Madhusudan, S
    Ganesan, TS
    CLINICAL BIOCHEMISTRY, 2004, 37 (07) : 618 - 635
  • [2] Protein tyrosine kinase inhibitors in cancer therapy
    Boutayeb, S.
    Zakkouri, F. Z.
    Aitelhaj, M.
    Mesmoudi, M.
    Boutayeb, A.
    Boutayeb, W.
    Mrabti, H.
    Errihani, H.
    PATHOLOGIE BIOLOGIE, 2012, 60 (04): : 229 - 233
  • [3] New tyrosine kinase and EGFR inhibitors in cancer therapy
    Rottlaender, D.
    Reda, S.
    Motloch, L. J.
    Hoppe, U. C.
    INTERNIST, 2011, 52 (10): : 1245 - +
  • [4] Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective
    Russo, Eleonora
    Spallarossa, Andrea
    Tasso, Bruno
    Villa, Carla
    Brullo, Chiara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [5] Tyrosine kinase inhibitors for the therapy of anaplastic thyroid cancer
    Antonelli, Alessandro
    Fallahi, Poupak
    Ulisse, Salvatore
    Ferrari, Silvia Martina
    Mazzi, Valeria
    Di Domenicantonio, Andrea
    Miccoli, Paolo
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 135 - 142
  • [6] A review on tyrosine kinase inhibitors for targeted breast cancer therapy
    Sankarapandian, Vidya
    Rajendran, Ramya Lakshmi
    Miruka, Conrad Ondieki
    Sivamani, Poornima
    Maran, Balu Alagar Venmathi
    Krishnamoorthy, Rajapandiyan
    Gangadaran, Prakash
    Ahn, Byeong-Cheol
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 263 : 155607
  • [7] Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
    Pottier, Charles
    Fresnais, Margaux
    Gilon, Marie
    Jerusalem, Guy
    Longuespee, Remi
    Sounni, Nor Eddine
    CANCERS, 2020, 12 (03)
  • [8] Receptor tyrosine kinase inhibitors in cancer
    Ebrahimi, Nasim
    Fardi, Elmira
    Ghaderi, Hajarossadat
    Palizdar, Sahar
    Khorram, Roya
    Vafadar, Reza
    Ghanaatian, Masoud
    Rezaei-Tazangi, Fatemeh
    Baziyar, Payam
    Ahmadi, Amirhossein
    Hamblin, Michael R.
    Aref, Amir Reza
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (04)
  • [9] Receptor tyrosine kinase inhibitors in cancer
    Nasim Ebrahimi
    Elmira Fardi
    Hajarossadat Ghaderi
    Sahar Palizdar
    Roya Khorram
    Reza Vafadar
    Masoud Ghanaatian
    Fatemeh Rezaei-Tazangi
    Payam Baziyar
    Amirhossein Ahmadi
    Michael R. Hamblin
    Amir Reza Aref
    Cellular and Molecular Life Sciences, 2023, 80
  • [10] Tyrosine kinase inhibitors in thyroid cancer
    Illouz, Frederic
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2010, 14 (07): : 210 - 214
12345